Abbvie INC Form 4 insider transactions

SVP, CSO, GLOBAL RESEARCH of AbbVie Inc., Thomas J. Hudson, reports disposition of shares to cover tax obligations.

Roopal Thakkar, SVP, CMO, GLOBAL THERAPEUTICS at AbbVie Inc., reported the disposal of 4,914 shares of common stock on February 28, 2024.

EVP, CHIEF BUS/STRAT OFFICER Nicholas Donoghoe reports disposing of 16,771 shares of AbbVie Inc. common stock on February 28, 2024.

AbbVie's Chairman and CEO, Richard Gonzalez, reported the acquisition and disposition of company stock on February 28, 2024.

Richard Gonzalez, Chairman and CEO of AbbVie, filed a Form 4 detailing changes in his beneficial ownership of the company's stock due to gift transactions.

EVP, GC AND SECRETARY Perry C. Siatis reports acquisition and disposal of AbbVie Inc. stock and derivative securities on February 23, 2024.